Hao Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hao Xie has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Fuying Pan
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Hui Peng
Department of Ophthalmology, Chongqing Key Laboratory for the Prevention and Treatment of Major Blinding Eye Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Jing Lu
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Jinquan Chen
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Lingda Wang
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication - Long Zhao
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 20 February 2023
- Published by Wiley in Journal of Nanomaterials
- Vol. 2023, 1-11
Exploration: Nanoparticles in the Diagnosis and Treatment of Retinal Diseases
In recent years, research on nanoparticles (NPs) has brought a new phase in the development of medicine. The term “NPs” refers to nanoscale particles, typically between 10 and 1,000 nm in size, that are within the range of cellular and molecular structures. Compared with traditional ophthalmic drugs, NPs can carry drugs to overcome obstacles, target drug delivery, prolong drug release, reduce drug toxicity, and can be used in gene therapy. After a brief introduction to the classification of NPs, we will focus on the potential applications of different NPs in the diagnosis and treatment of different retinal diseases and introduce innovative methods derived from NPs.
- 20 February 2023
- Published by Wiley in Journal of Nanomaterials
- Vol. 2023, 1-11
Open AccessExploration: Nanoparticles in the Diagnosis and Treatment of Retinal Diseases
In recent years, research on nanoparticles (NPs) has brought a new phase in the development of medicine. The term “NPs” refers to nanoscale particles, typically between 10 and 1,000 nm in size, that are within the range of cellular and molecular structures. Compared with traditional ophthalmic drugs, NPs can carry drugs to overcome obstacles, target drug delivery, prolong drug release, reduce drug toxicity, and can be used in gene therapy. After a brief introduction to the classification of NPs, we will focus on the potential applications of different NPs in the diagnosis and treatment of different retinal diseases and introduce innovative methods derived from NPs.